Vaccine Rollout Comes With S Challenge

Chris Manfuso is the national director of sales at Enovachem Pharmaceuticals, a role in which he is responsible for guiding the company to cooperate with the industries it serves. Chris Manfuso and Enovachem Pharmaceuticals are currently engaged with R&D into medicine for pain relief, but are also cognisant of the ongoing fight against COVID-19.

All over the world the development of a vaccine against COVID-19 was the goal for anyone who could feasibly do so. The task was successful, with even communist Cuba achieving a vaccine with a 92% effectiveness rate without a direct financial incentive. Although vaccines are widely available, there is constant debate on who should have them and why.

Even as the vaccine rolls out worldwide, questions continuously emerge about who it is safe to provide the vaccine for or even who should get the vaccine at all. Many pharmaceutical, federal, and scientific organizations feel the responsibility of continuously proving the safety of the vaccine to answer such questions; for example, the New England Journal of Medicine found in April of 2021 that the Pfizer vaccine is safe for pregnant women.